The Newest Licensed Cannabis Company in Ottawa’s National Capital Region Opens Doors and Has Begun Cultivation

OTTAWA, Ontario–(BUSINESS WIRE)–apollogreen has officially opened its Phase 1 state-of-the-art facility just off Highway 417 in Vars, near the Amazon Fulfillment Centre. The quickly growing cannabis genetics and micropropagation company threw a party for its supporters, suppliers, investors and partners just outside the secure facility to mark the occasion.

Says apollogreen CEO Tyler LeBlanc, “This project has been years in the making and now that the plantlets are in, it was time to thank everyone who propelled the company to this point in history. We are thrilled to launch, what we believe, will be a game changer in the cannabis industry globally.”

In attendance at the celebration were also MP Francis Drouin and Mayor Pierre Leroux, long-time supporters of the project.

apollogreen is an industrial-scale, B2B genetics and micropropagation company that supplies premium quality (safe, lab-tested, and disease-free) cannabis and hemp starter plants to the global market. In July 2019, Health Canada granted apollogreen three licences for standard cultivation, standard processing and federal medical sales.

Says Leroux, “We are pleased to welcome such an innovative company as apollogreen into our 417 Industrial Park. Our local businesses are such an important factor in why Russell Township has been named one of the best places to live in Canada, and we congratulate them on this wonderful day.”

The traditional method of starting a cannabis production of a new genetic can take months from seed to harvest. Licensed producers can drastically reduce non-revenue-producing growing time by purchasing apollogreen’s flower-ready starter plants. In only a few weeks, licensed producers can be harvesting high quality, highly differentiated cannabis and hemp products that are lab-tested and free of defects and contaminants.

apollogreen’s 5,000 sq. ft. Phase 1 facility is at 400 Commerce Street, Vars and has begun the innovative cultivation of plantlets. A Phase 2 building will be started after the next round of investment is complete.

Forward-Looking Statements

Certain statements contained in this news release constitute forward-looking statements or forward-looking information under applicable securities legislation. Forward-looking statements include all disclosures regarding possible events, conditions or results of operations that are based on assumptions about future economic conditions and courses of action. Forward-looking statements may also include, without limitation, any statement relating to future events, conditions or circumstances. The Company cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date they are made. Often, but not always, forward-looking statements can be identified by the use of words or phrases such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, “believes” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, and may be based on management’s current assumptions and expectations related to all aspects of the Company’s business, industry and the global economy. Further, the Company cautions that this foregoing list of material factors is not exhaustive and additional information identifying risks are detailed from time to time in the Company’s other continuous disclosure filings.

The forward-looking information contained in this press release represents expectations of the Company as of the date of this press release and accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. While the Company may elect to, it does not undertake to update this information at any particular time except as required in accordance with applicable securities laws.


Kimothy Walker

613 859 3753